SCHEMBL3681971

SCHEMBL3681971

C=C(C)C(=O)OC(C)c1ccccc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.40
ELANE P08246 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
CASP1 P29466 1/20 0.36
ACP3 P15309 1/20 0.36
ALDH1A1 P00352 4/20 0.35
TSHR P16473 2/20 0.34
HPGD P15428 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
NR3C2 P08235 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15019920 0.87 ADRA2A (0.35) ELANEADRA2AADRA2BADRA2CCASP1
SCHEMBL716320 0.83 GABRA1 (0.46) ELANECASP1ALDH1A1TSHRPOLB
SCHEMBL16672485 0.82 ESR1 (0.45) ESR1ADRA2AADRA2BADRA2CACP3
SCHEMBL7185345 0.82 POLB (0.45) ALDH1A1TSHRHPGDKDM4EPOLB
SCHEMBL27654695 0.82 HTT (0.41) ELANECASP1ALDH1A1TSHRCYP1A2
SCHEMBL26816137 0.82 ELANE (0.36) ELANECASP1ALDH1A1TSHRHPGD
SCHEMBL1130117 0.82 CASP1 (0.48) ELANECASP1ACP3ALDH1A1LMNA
Iodide SCHEMBL5873850 0.81 ELANE (0.36) ELANECASP1ALDH1A1TSHRHPGD
SCHEMBL21112015 0.81 ALDH1A1 (0.41) ESR1ELANEALDH1A1TSHRHPGD
Iodide SCHEMBL5873855 0.81 ELANE (0.36) ELANECASP1ALDH1A1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225325-A2 HIGH REFRACTIVE INDEX OPHTHALMIC DEVICE MATERIALS Alcon, Inc. (CH) 2010-09-08 EP claimed
WO-2009015256-A2 HIGH REFRACTIVE INDEX OPHTHALMIC DEVICE MATERIALS ALCON, INC. (CH) 2009-01-29 WO claimed
EP-1177227-A1 WATER PLASTICIZED HIGH REFRACTIVE INDEX POLYMER FOR OPHTHALMIC APPLICATIONS SURGIDEV CORPORATION (US) 2002-02-06 EP claimed
WO-2000061646-A1 WATER PLASTICIZED HIGH REFRACTIVE INDEX POLYMER FOR OPHTHALMIC APPLICATIONS SURGIDEV CORPORATION (US) 2000-10-19 WO claimed
EP-4267708-B1 THERMALLY RESPONSIVE BRUSH POLYMERS HAVING A COPOLYMER BACKBONE AND COPOLYMER ARMS INFINEUM INT LTD (GB) 2025-07-02 EP disclosed
WO-2025093198-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC DEVICES BAUSCH + LOMB IRELAND LIMITED (IE) 2025-05-08 WO disclosed
US-12281203-B2 Thermally responsive brush polymers having a copolymer backbone and copolymer arms INFINEUM INTERNATIONAL LIMITED (GB) 2025-04-22 US disclosed
US-20240309155-A1 Thermally Responsive Brush Polymers Having a Copolymer Backbone and Copolymer Arms INFINEUM INTERNATIONAL LIMITED (GB) 2024-09-19 US disclosed
EP-4267708-A1 THERMALLY RESPONSIVE BRUSH POLYMERS HAVING A COPOLYMER BACKBONE AND COPOLYMER ARMS Infineum International Limited (GB) 2023-11-01 EP disclosed
EP-4028480-A1 PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS ARKEMA FRANCE (FR) 2022-07-20 EP disclosed
WO-2022136384-A1 THERMALLY RESPONSIVE BRUSH POLYMERS HAVING A COPOLYMER BACKBONE AND COPOLYMER ARMS INFINEUM INTERNATIONAL LIMITED (GB) 2022-06-30 WO disclosed
EP-2869389-B1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME MITSUBISHI CHEM CORP (JP) 2019-11-13 EP disclosed
US-20150140448-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2015-05-21 US disclosed
EP-2869389-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME Mitsubishi Chemical Corporation (JP) 2015-05-06 EP disclosed
CN-104412441-A Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same MITSUBISHI CHEM CORP 2015-03-11 CN disclosed
US-20140107135-A1 PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AUSPEX PHARMACEUTICALS, INC. (US) 2014-04-17 US disclosed
EP-2032102-A2 OPTICAL MATERIAL AND METHOD FOR MODIFYING THE REFRACTIVE INDEX Bausch & Lomb Incorporated (US) 2009-03-11 EP disclosed
WO-2008002796-A2 OPTICAL MATERIAL AND METHOD FOR MODIFYING THE REFRACTIVE INDEX BAUSCH & LOMB INCORPORATED (US) 2008-01-03 WO disclosed
EP-1815275-A2 COPOLYMERIZABLE AZO COMPOUNDS AND ARTICLES CONTAINING THEM Advanced Medical Optics, Inc. (US) 2007-08-08 EP disclosed
WO-2006057840-A2 COPOLYMERIZABLE AZO COMPOUNDS AND ARTICLES CONTAINING THEM ADVANCED MEDICAL OPTICS, INC. (US) 2006-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107135-A1 PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 PLA2G1B, PLA2G4A, PLA2G4B ESR1 3991/4885ELANE 403/4885ADRA2A 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.